Seegene (Korea) Today
| 096530 Stock | KRW 24,650 400.00 1.65% |
PerformanceInsignificant
| Odds Of DistressLow
|
Seegene is trading at 24650.00 as of the 27th of February 2025, a 1.65 percent increase since the beginning of the trading day. The stock's open price was 24250.0. Seegene has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. The performance scores are derived for the period starting the 28th of January 2025 and ending today, the 27th of February 2025. Click here to learn more.
Seegene, Inc. manufactures and sells molecular diagnostics systems. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea. SEEGENE is traded on Korean Securities Dealers Automated Quotations in South Korea. The company has 25.99 M outstanding shares. More on Seegene
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Seegene Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Seegene's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Seegene or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Seegene (096530) is traded on KOSDAQ in Korea and employs 1,008 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 700.48 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Seegene's market, we take the total number of its shares issued and multiply it by Seegene's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Seegene operates under Biotechnology sector and is part of Health Care industry. The entity has 25.99 M outstanding shares.
Seegene has accumulated about 432.13 B in cash with 334.02 B of positive cash flow from operations.
Check Seegene Probability Of Bankruptcy
Ownership AllocationSeegene shows a total of 25.99 Million outstanding shares. Seegene maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Seegene Ownership Details
Seegene Risk Profiles
Although Seegene's alpha and beta are two of the key measurements used to evaluate Seegene's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.91 | |||
| Semi Deviation | 2.03 | |||
| Standard Deviation | 3.04 | |||
| Variance | 9.21 |
Seegene Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Seegene without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Seegene Corporate Management
Elected by the shareholders, the Seegene's board of directors comprises two types of representatives: Seegene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Seegene. The board's role is to monitor Seegene's management team and ensure that shareholders' interests are well served. Seegene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Seegene's outside directors are responsible for providing unbiased perspectives on the board's policies.
| HakSoo Lee | VP | Profile | |
| BooHyun Yang | Managing Director | Profile | |
| JongGi Cheon | VP Foundation | Profile | |
| JongKi Kim | Managing Director | Profile | |
| ByungKyun Ham | Managing Director | Profile | |
| HaeJoon Park | Managing Director | Profile | |
| Richard Creager | CEO Technologies | Profile |
Other Information on Investing in Seegene Stock
Seegene financial ratios help investors to determine whether Seegene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Seegene with respect to the benefits of owning Seegene security.